Heart drug tested to stop migraine triggers in the brain
NCT ID NCT04853797
Summary
This study tested whether a drug called ivabradine could prevent migraine attacks triggered by another drug, levcromakalim, in people who get migraines without aura. Thirty-seven participants received both drugs in a random order to see if ivabradine reduced the number or severity of triggered attacks. The main goal was to better understand the brain mechanisms behind migraine pain to help develop future treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE WITHOUT AURA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Danish Headache Center
Glostrup Municipality, 2600, Denmark
-
Danish Headache Centre, Rigshospitalet-Glostrup
Glostrup, Region Sjælland, 2600, Denmark
Conditions
Explore the condition pages connected to this study.